BIOMAT Database Logo BIOMAT Database Logo

Itraconazole does not interfere with fluorescence polarization immunoassay of serum digoxin. 1995

A F McClure, and C P Alderman, and P J Hayball

UI MeSH Term Description Entries
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D016231 Fluorescence Polarization Immunoassay Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labeled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations. Immunoassay, Fluorescence Polarization,Polarization Fluoroimmunoassay,Fluorescence Polarization Immunoassays,Fluoroimmunoassay, Polarization,Fluoroimmunoassays, Polarization,Immunoassays, Fluorescence Polarization,Polarization Fluoroimmunoassays,Polarization Immunoassay, Fluorescence,Polarization Immunoassays, Fluorescence
D017964 Itraconazole A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis. Orungal,R-51211,Sporanox,R 51211,R51211

Related Publications

A F McClure, and C P Alderman, and P J Hayball
Fluorescence polarization immunoassay of serum digoxin: comparison of the Abbott immunoassay with the Amerlex radioimmunoassay.
March 1983, Clinical chemistry,
A F McClure, and C P Alderman, and P J Hayball
Fluorescence polarization immunoassay cross-reactivity for digoxin.
April 1987, Drug intelligence & clinical pharmacy,
A F McClure, and C P Alderman, and P J Hayball
Effect of deproteinization on determination of serum digoxin by fluorescence polarization immunoassay.
February 1984, Clinical chemistry,
A F McClure, and C P Alderman, and P J Hayball
Evaluation of the fluorescence polarization immunoassay for quantitation of digoxin in serum.
January 1984, Therapeutic drug monitoring,
A F McClure, and C P Alderman, and P J Hayball
Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin.
April 1987, Clinical chemistry,
A F McClure, and C P Alderman, and P J Hayball
Analysis of digoxin concentrations in serum by fluorescence polarization immunoassay: an evaluation.
January 1984, Journal of analytical toxicology,
A F McClure, and C P Alderman, and P J Hayball
Modified fluorescence polarization immunoassay compared with radial partition immunoassay and a radioimmunoassay for digoxin.
November 1986, Clinical chemistry,
A F McClure, and C P Alderman, and P J Hayball
Effect of protein concentration on the determination of digoxin in serum by fluorescence polarization immunoassay.
November 1984, Clinical chemistry,
A F McClure, and C P Alderman, and P J Hayball
Fluorescence energy transfer immunoassay of digoxin in serum.
November 1985, Clinical chemistry,
A F McClure, and C P Alderman, and P J Hayball
Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay.
February 2010, Therapeutic drug monitoring,
Copied contents to your clipboard!